Keywords

Chlamydia; ovarian; cancer; bugs; drugs

Abstract

Chlamydia trachomatis (C. trachomatis) is being investigated as a potential vector to directly deliver anti-cancer peptides to ovarian cancer cells as part of the “Bugs as Drugs” initiative, offering a possible future treatment option for women diagnosed with ovarian cancer. Successful delivery of peptides from chlamydia to host cells first requires elementary bodies (EBs), the metabolically inactive form of chlamydia, to gain entry to host cells. To test the viability of this proposition, this project aimed foremost to demonstrate whether C. trachomatis is even capable of infecting ovarian cancer cell strains in vitro. Serovar L2 C. trachomatis was chosen and incubated along with three separate ovarian cancer cell lines: SK-OV-3, PA-1, and SW 626. A HeLa control sample was also grown alongside and incubated with chlamydia. Further experiments were done with the addition to the media of chloramphenicol (CHL), a known antibiotic and inhibitor of bacterial translation. CHL was added to ascertain whether infection could also preclude the development of reticulate bodies (RBs) (the metabolically active form of chlamydia) which could potentially harm healthy cells in the ovaries. Qualitatively, successful invasion of all three cell lines by chlamydia was observed. Encouragingly, the addition of CHL produced the same results but also demonstrated that host cell infections did not result in the development of RBs. Furthermore, western blots done on collected cell lysates showed consistency with other previously published research on chlamydial host cell infections, adding greater validity to the results. These findings encourage the continuation of future experiments that will test whether genetic modifications, such as the addition of nucleotides encoding the CT20 anti-cancer peptide, or administration of chlamydia along with different reagents, produces more promising results for a potential new ovarian cancer treatment option.

Thesis Completion Year

2025

Thesis Completion Semester

Fall

Thesis Chair

Jewett, Travis

College

College of Medicine

Department

Biomedical Sciences

Thesis Discipline

Biomedical Sciences

Language

English

Access Status

Campus Access

Length of Campus Access

5 years

Campus Location

Health Sciences Campus

Available for download on Friday, December 05, 2025

Share

COinS
 

Rights Statement

In Copyright